Incannex Healthcare Limited (IXHL) vs Nephros, Inc. (NEPH)
A side-by-side comparison of Incannex Healthcare Limited and Nephros, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IXHL
Incannex Healthcare Limited
$3.14HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
NEPH
Nephros, Inc.
$3.51HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
Total return — IXHL vs NEPH
growth of $100 · dividends reinvested · last 5yIXHL -99.8% (-71.8%/yr)NEPH -20.2% (-4.4%/yr)NEPH compounded faster over this window
Log scale — wide-divergence pair
IXHL NEPH
IXHL vs NEPH: by the numbers
- •NEPH is the larger company ($38M vs $38M market cap).
- •NEPH is profitable (8.38% net margin) while IXHL runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | IXHL | NEPH |
|---|---|---|
| P/E ratio | N/A | 22.12 |
| Forward P/E | N/A | 22.40 |
| P/S ratio | N/A | 1.84 |
| P/B ratio | 0.56 | 3.18 |
| EV / EBITDA | N/A | 19.42 |
Profitability
| Metric | IXHL | NEPH |
|---|---|---|
| Gross margin | 0.00% | 60.31% |
| Operating margin | 0.00% | 7.92% |
| Net margin | 0.00% | 8.38% |
| ROE | -28.65% | 14.51% |
| ROIC | -32.18% | 12.67% |
Growth (annualized)
| Metric | IXHL | NEPH |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 16.99% |
| Total return CAGR (5Y) | N/A | -15.93% |
Frequently asked
- Is IXHL or NEPH more profitable?
- NEPH runs the higher net margin — IXHL at 0.00% versus NEPH at 8.38%.
Go deeper
Dig into the metrics
Nephros P/E ratioIncannex Healthcare ROENephros ROEIncannex Healthcare operating marginNephros operating marginIncannex Healthcare revenue growthNephros revenue growthIncannex Healthcare free cash flowNephros free cash flow
Incannex Healthcare & Nephros appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.